10.1007/s40204-017-0063-0

Poly(lactic-co-glycolic) acid drug delivery systems through transdermal pathway: an overview

PDF HTML
  • Lucas Naves1,
  • Chetna Dhand2,
  • Luis Almeida3,
  • Lakshminarayanan Rajamani2,
  • Seeram Ramakrishna4,
  • Graça Soares*3,
  1. Center for Textile Science and Technology, University of Minho, Guimarães, PT CAPES Foundation, Ministry of Education of Brazil, Brasília, BR Department of Mechanical Engineering, Center for Nanofibers and Nanotechnology, National University of Singapore, Singapore, 117581, SG
  2. Anti-Infectives Research Group, Singapore Eye Research Institute, Singapore, 169856, SG
  3. Center for Textile Science and Technology, University of Minho, Guimarães, PT
  4. Department of Mechanical Engineering, Center for Nanofibers and Nanotechnology, National University of Singapore, Singapore, 117581, SG Guangdong-Hongkong-Macau Institute of CNS Regeneration (GHMICR), Jinan University, Guangzhou, 510632, CN
Cover Image

Published in Issue 2017-02-06

How to Cite

Naves, L., Dhand, C., Almeida, L., Rajamani, L., Ramakrishna, S., & Soares, G. (2017). Poly(lactic-co-glycolic) acid drug delivery systems through transdermal pathway: an overview. Progress in Biomaterials, 6(1-2 (May 2017). https://doi.org/10.1007/s40204-017-0063-0
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Abstract In past few decades, scientists have made tremendous advancement in the field of drug delivery systems (DDS), through transdermal pathway, as the skin represents a ready and large surface area for delivering drugs. Efforts are in progress to design efficient transdermal DDS that support sustained drug release at the targeted area for longer duration in the recommended therapeutic window without producing side-effects. Poly(lactic- co -glycolic acid) (PLGA) is one of the most promising Food and Drug Administration approved synthetic polymers in designing versatile drug delivery carriers for different drug administration routes, including transdermal drug delivery. The present review provides a brief introduction over the transdermal drug delivery and PLGA as a material in context to its role in designing drug delivery vehicles. Attempts are made to compile literatures over PLGA-based drug delivery vehicles, including microneedles, nanoparticles, and nanofibers and their role in transdermal drug delivery of different therapeutic agents. Different nanostructure evaluation techniques with their working principles are briefly explained.

Keywords

  • Drug delivery system,
  • Transdermal drug delivery,
  • PLGA,
  • Microneedles,
  • Electrospinning technique
PDF HTML

References

  1. Acharya and Sahoo (2011) PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect (pp. 170-183) https://doi.org/10.1016/j.addr.2010.10.008
  2. Ajalloueian et al. (2014) Emulsion electrospinning as an approach to fabricate PLGA/chitosan nanofibers for biomedical applications (pp. 1-13) https://doi.org/10.1155/2014/475280
  3. Alvarez-Romn et al. (2004) Skin penetration and distribution of polymeric nanoparticles (pp. 53-62) https://doi.org/10.1016/j.jconrel.2004.06.015
  4. Antonini et al. (2006) Fate of manganese associated with the inhalation of welding fumes: potential neurological effects 27(3) (pp. 304-310) https://doi.org/10.1016/j.neuro.2005.09.001
  5. Bilati et al. (2005) Poly(d, l-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method processing and formulation issues for enhanced entrapment efficiency 22(2) (pp. 205-214) https://doi.org/10.1080/02652040400026442
  6. Bottaro et al. (2002) Molecular signaling in bioengineered tissue microenvironments (pp. 143-153) https://doi.org/10.1111/j.1749-6632.2002.tb03068.x
  7. Brain KR, Walters KA, Watkinson AC (2002) Methods for studying percutaneous absorption. In: Walters KA (ed) Dermatological and transdermal formulations. Marcel Dekker, Inc, pp 195–267. doi:
  8. 10.1201/9780824743239.ch5
  9. Contreras JEL (2007) Human skin drug delivery using biodegradable PLGA nanoparticles. Saarlandes University.
  10. http://scidok.sulb.uni-saarland.de/volltexte/2007/1118/pdf/Luengo_Contreras.pdf
  11. . Accessed 5 Apr 2016
  12. Demir et al. (2013) Characterization of polymeric microneedle arrays for transdermal drug delivery 8(10) (pp. 1-9) https://doi.org/10.1371/journal.pone.0077289
  13. Dinarvand et al. (2011) Poly(lactide-co-glycolide) nanoparticles for controlled delivery of anticancer agents (pp. 877-895) https://doi.org/10.2147/IJN.S18905
  14. Donnelly et al. (2011) Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique 28(1) (pp. 41-57) https://doi.org/10.1007/s11095-010-0169-8
  15. Garcia-Garcia et al. (2005) A methodology to study intracellular distribution of nanoparticles in brain endothelial cells (pp. 310-314) https://doi.org/10.1016/j.ijpharm.2005.03.030
  16. Gilding DM, Reed AM (1979) Biodegradable polymers for use in surgery. Poly(glycolic)/poly(lactic acid) homo and copolymers. Polymers 20:1459–1464
  17. Hafner (2006) Characterization Facility, University of Minnesota
  18. Jacob (1952) An introduction to electron optics 20(1) https://doi.org/10.1119/1.1933113
  19. Jin et al. (2013) Tissue engineered plant extracts as nanofibrous wound dressing 34(3) (pp. 724-734) https://doi.org/10.1016/j.biomaterials.2012.10.026
  20. Ke et al. (2012) Multidrug release based on microneedle arrays filled with pH-responsive PLGA hollow microspheres (pp. 5156-5165) https://doi.org/10.1016/j.biomaterials.2012.03.056
  21. Kocbek et al. (2007) Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody 120(1–2) (pp. 18-26) https://doi.org/10.1016/j.jconrel.2007.03.012
  22. Kohli and Alpar (2004) Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge (pp. 13-17) https://doi.org/10.1016/j.ijpharm.2003.10.038
  23. Korrapati et al. (2015) Recent advancements in nanotechnological strategies in selection, design and delivery of biomolecules for skin regeneration (pp. 747-765) https://doi.org/10.1016/j.msec.2016.05.074
  24. Langer (1998) Drug delivery and targeting 392(6679) (pp. 5-10) https://doi.org/10.1517/14728222.2.1.145
  25. Langer (2004) Transdermal drug delivery: past progress, current status, and future prospects (pp. 557-558) https://doi.org/10.1016/j.addr.2003.10.021
  26. Lewis DH (1990) Controlled release of bioactive agents from lactide/glycolide polymers. In: Chasin R, Langer M (eds) Biodegradable polymers as drug delivery systems. Marcel Dekker, New York, pp 1–41
  27. Li et al. (2003) Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage 111(4) (pp. 455-460) https://doi.org/10.1289/ehp.6000
  28. Luengo et al. (2006) Influence of nanoencapsulation on human skin transport of flufenamic acid (pp. 190-197) https://doi.org/10.1159/000093114
  29. Luu et al. (2003) Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers (pp. 341-353) https://doi.org/10.1016/S0168-3659(03)00097-X
  30. Meng et al. (2010) Electrospinning of PLGA/gelatin randomly-oriented and aligned nanofibers as potential scaffold in tissue engineering (pp. 1204-1210) https://doi.org/10.1016/j.msec.2010.06.018
  31. Meng et al. (2011) Preparation and characterization of electrospun PLGA/gelatin nanofibers as a potential drug delivery system 84(1) (pp. 97-102) https://doi.org/10.1016/j.colsurfb.2010.12.022
  32. Panyam and Labhasetwar (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue 55(3) (pp. 329-347) https://doi.org/10.1016/S0169-409X(02)00228-4
  33. Park et al. (2006) Polymer microneedles for controlled-release drug delivery (pp. 1008-1019) https://doi.org/10.1007/s11095-006-0028-9
  34. Petkov (2008) Nanostructure by high-energy X-ray diffraction 11(11) (pp. 28-38) https://doi.org/10.1016/S1369-7021(08)70236-0
  35. Porter et al. (2006) Uptake of C60 by human monocyte macrophages, its localization and implications for toxicity: studied by high resolution electron microscopy and electron tomography 2(4) (pp. 409-419) https://doi.org/10.1016/j.actbio.2006.02.006
  36. Qi et al. (2016) Controlled release of doxorubicin from electrospun MWCNTs/PLGA hybrid nanofibers 34(9) (pp. 1047-1059) https://doi.org/10.1007/s10118-016-1827-z
  37. Soto et al. (2005) Comparative in vitro cytotoxicity assessment of some manufactured nanoparticulate materials characterized by transmissionelectron microscopy 7(2–3) (pp. 145-169) https://doi.org/10.1007/s11051-005-3473-1
  38. Sridhar et al. (2015) Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals (pp. 790-814) https://doi.org/10.1039/C4CS00226A
  39. Stracke et al. (2006) Multiphoton microscopy for the investigation of dermal penetration of nanoparticle-borne drugs (pp. 2224-2233) https://doi.org/10.1038/sj.jid.5700374
  40. Takenaka et al. (2001) Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats (pp. 547-551) https://doi.org/10.2307/3454667
  41. Wu and Wise (1995) Synthesis and properties of biodegradable lactic/glycolic acid polymers (pp. 1015-1054) Marcel Dekker
  42. Xia et al. (2006) Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm 6(8) (pp. 1794-1807) https://doi.org/10.1021/nl061025k
  43. Xiao et al. (2005) Antioxidant effects of water-soluble fullerene derivatives against ultraviolet ray or peroxylipid through their action of scavenging the reactive oxygen species in human skin keratinocytes (pp. 351-358) https://doi.org/10.1016/j.biopha.2005.02.004
  44. Zhang et al. (2013) Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus (pp. 3745-3756) https://doi.org/10.2147/IJN.S49835
  45. Zhang et al. (2014) Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases 11(3) (pp. 393-407) https://doi.org/10.1002/wnan.1211.Polymeric
  46. Zheng D, Giljohann DA, Chen DL, Massich MD, Wang X-Q, Iordanov H, Mirkin CA, Paller AS (2012) Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Nat Acad Sci 109(30):11975–11980. doi:
  47. 10.1073/pnas.1118425109